[Alcohol withdrawal syndrome management. Preventive and curative treatment].
Couzigou
Patrice
P
Hépato-Gastroentérologie, Hôpital du Haut-Lévêque, Avenue de Magellan, 33604 Pessac Cedex.
Ledinghen
Victor
V
D000316:Adrenergic alpha-Agonists / Q000627:therapeutic use; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D014151:Anti-Anxiety Agents / Q000627:therapeutic use; D001569:Benzodiazepines; D003000:Clonidine / Q000627:therapeutic use; D003131:Combined Modality Therapy; D000431:Ethanol / Q000009:adverse effects*; D006801:Humans; D008274:Magnesium / Q000627:therapeutic use; D011613:Psychotherapy / Q000379:methods; D016320:Substance Abuse Treatment Centers; D013375:Substance Withdrawal Syndrome / Q000209:etiology* / Q000503:physiopathology / Q000628:therapy*
D000316:Adrenergic alpha-Agonists; D000319:Adrenergic beta-Antagonists; D014151:Anti-Anxiety Agents; D001569:Benzodiazepines; D000431:Ethanol; D008274:Magnesium; D003000:Clonidine
Le sevrage du malade alcoolo-dépendant (syndrome de sevrage alcoolique - traitement préventif et curatif).